<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01785342</url>
  </required_header>
  <id_info>
    <org_study_id>H-31755</org_study_id>
    <nct_id>NCT01785342</nct_id>
  </id_info>
  <brief_title>DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules</brief_title>
  <acronym>DECAMP-1</acronym>
  <official_title>Detection of Early Lung Cancer Among Military Personnel Study 1 (DECAMP-1): Diagnosis and Surveillance of Indeterminate Pulmonary Nodules</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American College of Radiology Imaging Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal is to improve the efficiency of the diagnostic follow-up of patients with
      indeterminate pulmonary nodules by determining whether biomarkers for lung cancer diagnosis
      that are measured in minimally invasive biospecimens are able to distinguish malignant from
      benign pulmonary nodules that are incidentally detected in high-risk smokers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Detection of Early lung Cancer Among Military Personnel (DECAMP) consortium is a
      multidisciplinary and translational research program that includes 7 Veterans Administration
      Hospitals (VAH), the 4 designated Military Treatment Facilities (MTF) and one academic
      hospital as clinical study sites, several molecular biomarker laboratories, along with
      Biostatics, Bioinformatics, Pathology and Biorepository cores. The DECAMP Coordinating Center
      will facilitate rapid selection, design and execution of clinical studies within this
      multi-institutional consortium. The goal will be accomplished by recruiting 500 smokers with
      indeterminate pulmonary nodules (0.7cm - 3.0cm) on chest CT who will undergo fiberoptic
      bronchoscopy and will be followed for 2 years until a final diagnosis is made. The diagnostic
      performance of four previously established lung cancer biomarkers in this cohort will be
      validated; 1) a gene-expression biomarker measured in bronchial airway brushings; 2) a
      proteomic signatures measured in bronchial airway biopsies; 3) a proteomic signature measured
      in serum; and 4) a signature of serum cytokines. The added value of the molecular markers to
      clinical and imaging markers routinely used in the diagnostic work up of these patients and
      develop an integrated model (i.e. clinical, imaging &amp; molecular markers) that results in the
      most robust diagnostic predictor will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2013</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung Cancer</measure>
    <time_frame>2 years</time_frame>
    <description>Subjects will be identified as Lung Cancer or no Lung Cancer (through diagnosis) within the 2 year followup period.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Indeterminate Pulmonary Nodule</arm_group_label>
    <description>The goal will be accomplished by recruiting 500 smokers with indeterminate pulmonary nodules (0.7cm - 3.0cm) on chest CT who will undergo fiberoptic bronchoscopy and will be followed for 2 years until a final diagnosis is made. Biosample and imaging collection will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biosample and Imaging Collection</intervention_name>
    <description>Collection of listed biosamples and CT imaging.</description>
    <arm_group_label>Indeterminate Pulmonary Nodule</arm_group_label>
    <other_name>Blood,</other_name>
    <other_name>Urine,</other_name>
    <other_name>Buccal Scraping,</other_name>
    <other_name>Nasal,</other_name>
    <other_name>Bronchial Brushing,</other_name>
    <other_name>Bronchial Biopsy,</other_name>
    <other_name>Lung Tissue,</other_name>
    <other_name>Sputum,</other_name>
    <other_name>CT Imaging of Chest</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Urine, Sputum, Nasal brushing, Buccal scraping, Bronchial Biopsy, Bronchial brushing,
      lung tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Military personnel
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  45 years of age or older;

          -  Initial diagnosis of indeterminate pulmonary nodule (0.7-3.0 cm);

          -  Smoking status: Current or former smoker with â‰¥ 20 pack years (pack years = number of
             packs per day X number of years smoked)

          -  Willing to undergo fiberoptic bronchoscopy;

          -  Able to tolerate all biospecimen collection as required by protocol;

          -  Able to comply with standard of care follow up visits including clinical exams,
             diagnostic work-ups, and imaging for a minimum of two years;

          -  Able to fill out Patient Lung History questionnaire;

          -  Willing and able to provide a written informed consent.

        Exclusion Criteria:

          -  History or previous diagnosis of lung cancer;

          -  Diagnosis of pure ground glass opacities on chest CT;

          -  Contraindications to nasal brushing or fiberoptic bronchoscopy including ulcerative
             nasal disease, hemodynamic instability, severe obstructive airway disease, unstable
             cardiac or pulmonary disease; inability to protect airway or altered level of
             consciousness;

          -  Allergies to any local anesthetic that may be used to obtain biosamples in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Avrum Spira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mitchell Schnall, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American College of Radiology Imaging Network</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Avrum Spira, MD</last_name>
    <email>aspira@bu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elizabeth Moses, PhD</last_name>
    <phone>617-414-6994</phone>
    <email>emoses@bu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Regents of the University of California LA (Los Angeles VA Healthcare System)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Dubinett, MD</last_name>
      <email>SDubinett@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Fran Rosen</last_name>
      <email>frosen@mednet.ucla.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Dubinett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John S Parrish, MD</last_name>
      <email>john.parrish@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Raechel DelRosario</last_name>
      <email>rdelrosario@acr.org</email>
    </contact_backup>
    <investigator>
      <last_name>John S Parrish, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Denver Research Institute</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Keith, MD</last_name>
      <email>Robert.Keith@ucdenver.edu</email>
    </contact>
    <contact_backup>
      <last_name>Mary Jackson</last_name>
      <email>mary.k.jackson@ucdenver.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Keith, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20814</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Browning, MD</last_name>
      <email>robert.browningjr@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Maggie Nellissery</last_name>
      <email>mnellissery@acr.org</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Browning, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston VA Research Institute, Inc</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronald Goldstein, MD</last_name>
      <email>Ronald.Goldstein@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Kathleen LaCerda</last_name>
      <email>kathleen.lacerda@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald Goldstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Research Inc. Roswell Park Division</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Reid, PhD</last_name>
      <email>Mary.Reid@roswellpark.org</email>
    </contact>
    <contact_backup>
      <last_name>Michele Cooper</last_name>
      <email>michele.cooper@roswellpark.org</email>
    </contact_backup>
    <investigator>
      <last_name>Mary Reid, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Trustees of University of Pennsylvania (Philadelphia VA Medical Center)</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anil Vachani, MD</last_name>
      <email>avachani@mail.med.upenn.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kristina Maletteri</last_name>
      <email>kdmaletteri@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Anil Vachani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Veterans Research Foundation of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Atwood, MD</last_name>
      <email>atwoodcw@upmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kathryn Little</last_name>
      <email>kathryn.little@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Atwood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Middle Tennessee Research Institute (Vanderbilt University)</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Massion, MD</last_name>
      <email>pierre.massion@vanderbilt.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rena Burns</last_name>
      <email>rena.burns@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Pierre Massion, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dallas VA Research Corporation</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Battaile, MD</last_name>
      <email>JohnT.Battaile@va.gov</email>
    </contact>
    <investigator>
      <last_name>John Battaile, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>San Antonio Military Medical Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Morris, MD</last_name>
      <email>michael.morris1@us.army.mil</email>
    </contact>
    <contact_backup>
      <last_name>Denise Woods</last_name>
      <email>dwoods@acr.org</email>
    </contact_backup>
    <investigator>
      <last_name>Michael Morris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Naval Medical Center Portsmouth</name>
      <address>
        <city>Portsmouth</city>
        <state>Virginia</state>
        <zip>23708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenneth More, MD</last_name>
      <email>kenneth.more@med.navy.mil</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Kinsey</last_name>
      <email>jkinsey@acr.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kenneth More, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2013</study_first_submitted>
  <study_first_submitted_qc>February 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2013</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Multiple Pulmonary Nodules</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

